The aim of the present study was to evaluate the potential association between the immunohistochemical expression of SRSF1 and the risk of the local recurrence of a series of 52 surgically excised BCCs with histological tumor-free margins (47 non-recurrent versus 5 recurrent tumors). The gene discussed is SRSF1; the disease is neoplasm.